Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study ; volume:22 ; number:1 ; day:10 ; month:8 ; year:2022 ; pages:1-13 ; date:12.2022
BMC gastroenterology ; 22, Heft 1 (10.8.2022), 1-13, 12.2022
- Creator
-
Lin, Chen-Yuan
Lien, Ming-Yu
Chen, Chi-Ching
Fang, Hsin-Yuan
Lin, Yu-Sen
Chen, Chien-Kuang
Chen, Jian-Xun
Lu, Ting-Yu
Huang, Tzu-Min
Hsieh, Te-Chun
Sun, Shung-Shung
Li, Chia-Chin
Chien, Chun-Ru
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-022-02464-x
- URN
-
urn:nbn:de:101:1-2022102603014344966226
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Chen-Yuan
- Lien, Ming-Yu
- Chen, Chi-Ching
- Fang, Hsin-Yuan
- Lin, Yu-Sen
- Chen, Chien-Kuang
- Chen, Jian-Xun
- Lu, Ting-Yu
- Huang, Tzu-Min
- Hsieh, Te-Chun
- Sun, Shung-Shung
- Li, Chia-Chin
- Chien, Chun-Ru
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial